Teladoc Health is a leading telehealth company that provides virtual healthcare services, connecting patients with a wide range of healthcare professionals through digital platforms. The company offers various services, including remote consultations, mental health support, chronic condition management, and preventive care. By leveraging technology, Teladoc facilitates access to healthcare for individuals regardless of their location, aiming to improve health outcomes and enhance the patient experience. Their comprehensive solutions cater to both individual consumers and large employers, helping to make healthcare more accessible and efficient. Read More
A number of stocks fell in the afternoon session after markets faded the Nvidia rally in the morning session, as investors remained uncertain about future rate cuts.
KeyCorp, through its KeyBanc capital markets division, has issued a significantly more pessimistic forecast for LifeMD (NASDAQ: LFMD) stock, dramatically lowering its price objective to $8.00 from a previous $12.00. This downgrade reflects growing concerns over the telehealth company's financial performance, operational efficiency, and competitive landscape. The immediate
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Teladoc (NYSE:TDOC) and its peers.
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor.
The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
A number of stocks fell in the afternoon session after the broader U.S. stock market declined amid investor caution and a pullback in technology stocks.
NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee.
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on.
However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
Teladoc’s third quarter results were met with a negative market reaction, as revenue landed in line with Wall Street’s expectations but continued to decline year-over-year. Management attributed the performance to ongoing challenges in its U.S. direct-to-consumer mental health segment and a mix shift towards visit-based revenues. CEO Charles Divita highlighted the company’s efforts to enhance product offerings and drive greater engagement across its integrated care and mental health platforms. He stated, "We know that we have important work ahead of us," acknowledging that pressures on affordability and rising costs remain substantial across the healthcare landscape.
Shares of digital medical services platform Teladoc Health (NYSE:TDOC) fell 6% in the afternoon session after analyst forecasts pointed to a significant slowdown in the company's future growth compared to the broader industry. Analysts watching the company estimated its growth at only 2.2% per year over the next three years. In contrast, the rest of the healthcare technology industry was projected to expand by a much more attractive 12% annually. This large gap in expected performance likely made investors uncomfortable, as it suggested Teladoc could be facing a less prosperous future than its peers.
Shares of digital medical services platform Teladoc Health (NYSE:TDOC) jumped 6.3% in the morning session after the company reported third-quarter financial results that surpassed Wall Street's revenue expectations, even as other key metrics declined compared to the previous year.
Digital medical services platform Teladoc Health (NYSE:TDOC) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 2.2% year on year to $626.4 million. The company expects next quarter’s revenue to be around $637 million, close to analysts’ estimates. Its GAAP loss of $0.28 per share was 9.2% below analysts’ consensus estimates.
Digital medical services platform Teladoc Health (NYSE:TDOC) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 2.2% year on year to $626.4 million. The company expects next quarter’s revenue to be around $637 million, close to analysts’ estimates. Its GAAP loss of $0.28 per share was 9.2% below analysts’ consensus estimates.
Teladoc's Q3 2025 results show mixed performance with revenue near expectations and a narrowed non-GAAP loss, while its BetterHelp segment continues to face challenges.
NEW YORK, NY, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended September 30, 2025 (“Third Quarter 2025”). Unless otherwise noted, percentage and other changes are relative to the three months ended September 30, 2024 (“Third Quarter 2024”).
